MR enterography with oral contrast agent composed of methylcellulose, low-dose barium sulfate, sorbitol, and lactulose: Assessment of diagnostic performance, reliability, image quality, and patient tolerance

Evrimler S., ALGIN O.

Clinical Imaging, cilt.40, sa.3, ss.523-530, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40 Sayı: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.clinimag.2016.01.002
  • Dergi Adı: Clinical Imaging
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.523-530
  • Anahtar Kelimeler: Enterography, Inflammatory bowel disease, MRI, Oral contrast agents, Small bowel imaging
  • Ankara Üniversitesi Adresli: Hayır

Özet

Objective: The objective was to show efficiency of magnetic resonance enterography (MRE) with our previously assessed new oral contrast agent. Materials and methods: Each bowel segments was evaluated for luminal distension, wall conspicuity, wall thickening, and hyperintensity on fat-saturated (FS) T2-weighted and contrast enhancement on postcontrast FS T1-weighted images. Also, consensus scoring results of MRE exams were compared with the gold standard tests in terms of active inflammatory bowel disease detection. Results: Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of MRE for active inflammatory bowel disease detection were 62%, 98%, 80%, 96%, and 71.4%, respectively. Conclusion: MRE obtained with the new mixture has a high reliability and shows good correlation with endoscopic examination ± biopsy.